# Haverty Furniture Companies Inc: financial statements, quarterly

HVT · NYSE · CIK 216085 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hvt.md) · [Financials](/companies/hvt/financials.md) · [Filings](/companies/hvt/filings.md) · [Insiders](/companies/hvt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hvt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [220](/filings/0001628280-24-044893.md) | [211 d](/filings/0001628280-26-012199.md) | [184](/filings/0001628280-25-021749.md) | [179](/filings/0001628280-25-037688.md) | [176](/filings/0001628280-25-047712.md) | [184 d](/filings/0001628280-26-012199.md) | [182](/filings/0001628280-26-031027.md) | [181](/filings/0001628280-26-052652.md) | [194](/filings/0001628280-25-047712.md) | [202 d](/filings/0001628280-26-012199.md) | [189](/filings/0001628280-26-031027.md) | [195](/filings/0001628280-26-052652.md) |
| Cost of revenue | $m | [86.3](/filings/0001628280-24-044893.md) | [79.3 d](/filings/0001628280-26-012199.md) | [73.0](/filings/0001628280-25-021749.md) | [70.7](/filings/0001628280-25-037688.md) | [70.0](/filings/0001628280-25-047712.md) | [70.2 d](/filings/0001628280-26-012199.md) | [70.5](/filings/0001628280-26-031027.md) | [70.9](/filings/0001628280-26-052652.md) | [77.2](/filings/0001628280-25-047712.md) | [79.9 d](/filings/0001628280-26-012199.md) | [72.8](/filings/0001628280-26-031027.md) | [75.2](/filings/0001628280-26-052652.md) |
| Gross profit | $m | [134](/filings/0001628280-24-044893.md) | [131 d](/filings/0001628280-26-012199.md) | [111](/filings/0001628280-25-021749.md) | [108](/filings/0001628280-25-037688.md) | [106](/filings/0001628280-25-047712.md) | [114 d](/filings/0001628280-26-012199.md) | [111](/filings/0001628280-26-031027.md) | [110](/filings/0001628280-26-052652.md) | [117](/filings/0001628280-25-047712.md) | [122 d](/filings/0001628280-26-012199.md) | [116](/filings/0001628280-26-031027.md) | [120](/filings/0001628280-26-052652.md) |
| Selling, general and administrative | $m | [113](/filings/0001628280-24-044893.md) | [115 d](/filings/0001628280-26-012199.md) | [109](/filings/0001628280-25-021749.md) | [103](/filings/0001628280-25-037688.md) | [101](/filings/0001628280-25-047712.md) | [106 d](/filings/0001628280-26-012199.md) | [107](/filings/0001628280-26-031027.md) | [107](/filings/0001628280-26-052652.md) | [112](/filings/0001628280-25-047712.md) | [112 d](/filings/0001628280-26-012199.md) | [111](/filings/0001628280-26-031027.md) | [113](/filings/0001628280-26-052652.md) |
| Income tax | $m | [5.8](/filings/0001628280-24-044893.md) | [3.5 d](/filings/0001628280-26-012199.md) | [0.8](/filings/0001628280-25-021749.md) | [2.0](/filings/0001628280-25-037688.md) | [1.9](/filings/0001628280-25-047712.md) | [1.4 d](/filings/0001628280-26-012199.md) | [1.5](/filings/0001628280-26-031027.md) | [1.6](/filings/0001628280-26-052652.md) | [1.7](/filings/0001628280-25-047712.md) | [2.3 d](/filings/0001628280-26-012199.md) | [1.7](/filings/0001628280-26-031027.md) | [2.1](/filings/0001628280-26-052652.md) |
| Net income | $m | [17.2](/filings/0001628280-24-044893.md) | [15.0 d](/filings/0001628280-26-012199.md) | [2.4](/filings/0001628280-25-021749.md) | [4.4](/filings/0001628280-25-037688.md) | [4.9](/filings/0001628280-25-047712.md) | [8.2 d](/filings/0001628280-26-012199.md) | [3.8](/filings/0001628280-26-031027.md) | [2.7](/filings/0001628280-26-052652.md) | [4.7](/filings/0001628280-25-047712.md) | [8.5 d](/filings/0001628280-26-012199.md) | [4.3](/filings/0001628280-26-031027.md) | [5.3](/filings/0001628280-26-052652.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported
- Basic EPS: not reported

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [134](/filings/0001628280-23-036671.md) | [121](/filings/0001628280-25-010869.md) | [112](/filings/0001628280-24-021092.md) | [110](/filings/0001628280-24-035196.md) | [121](/filings/0001628280-24-044893.md) | [120](/filings/0001628280-26-012199.md) | [112](/filings/0001628280-25-021749.md) | [107](/filings/0001628280-25-037688.md) | [130](/filings/0001628280-25-047712.md) | [125](/filings/0001628280-26-052652.md) | [107](/filings/0001628280-26-031027.md) | [104](/filings/0001628280-26-052652.md) |
| Current assets | $m | [271](/filings/0001628280-23-036671.md) | [252](/filings/0001628280-25-010869.md) | [241](/filings/0001628280-24-021092.md) | [240](/filings/0001628280-24-035196.md) | [250](/filings/0001628280-24-044893.md) | [239](/filings/0001628280-26-012199.md) | [233](/filings/0001628280-25-021749.md) | [236](/filings/0001628280-25-037688.md) | [251](/filings/0001628280-25-047712.md) | [249](/filings/0001628280-26-052652.md) | [241](/filings/0001628280-26-031027.md) | [237](/filings/0001628280-26-052652.md) |
| Total assets | $m | [677](/filings/0001628280-23-036671.md) | [654](/filings/0001628280-25-010869.md) | [641](/filings/0001628280-24-021092.md) | [642](/filings/0001628280-24-035196.md) | [659](/filings/0001628280-24-044893.md) | [649](/filings/0001628280-26-012199.md) | [643](/filings/0001628280-25-021749.md) | [643](/filings/0001628280-25-037688.md) | [652](/filings/0001628280-25-047712.md) | [649](/filings/0001628280-26-052652.md) | [647](/filings/0001628280-26-031027.md) | [656](/filings/0001628280-26-052652.md) |
| Current liabilities | $m | [151](/filings/0001628280-23-036671.md) | [138](/filings/0001628280-25-010869.md) | [131](/filings/0001628280-24-021092.md) | [130](/filings/0001628280-24-035196.md) | [138](/filings/0001628280-24-044893.md) | [132](/filings/0001628280-26-012199.md) | [129](/filings/0001628280-25-021749.md) | [131](/filings/0001628280-25-037688.md) | [143](/filings/0001628280-25-047712.md) | [133](/filings/0001628280-26-052652.md) | [131](/filings/0001628280-26-031027.md) | [140](/filings/0001628280-26-052652.md) |
| Total liabilities | $m | [360](/filings/0001628280-23-036671.md) | [346](/filings/0001628280-25-010869.md) | [334](/filings/0001628280-24-021092.md) | [335](/filings/0001628280-24-035196.md) | [352](/filings/0001628280-24-044893.md) | [341](/filings/0001628280-26-012199.md) | [337](/filings/0001628280-25-021749.md) | [338](/filings/0001628280-25-037688.md) | [346](/filings/0001628280-25-047712.md) | [341](/filings/0001628280-26-052652.md) | [341](/filings/0001628280-26-031027.md) | [362](/filings/0001628280-26-052652.md) |
| Shareholders' equity | $m | [316](/filings/0001628280-24-044893.md) | [308](/filings/0001628280-26-012199.md) | [307](/filings/0001628280-25-037688.md) | [307](/filings/0001628280-25-047712.md) | [308](/filings/0001628280-25-047712.md) | [308](/filings/0001628280-26-052652.md) | [305](/filings/0001628280-26-052652.md) | [305](/filings/0001628280-26-052652.md) | [306](/filings/0001628280-25-047712.md) | [308](/filings/0001628280-26-052652.md) | [307](/filings/0001628280-26-052652.md) | [294](/filings/0001628280-26-052652.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [39.2 d](/filings/0001628280-24-044893.md) | [17.8 d](/filings/0001628280-26-012199.md) | [3.1](/filings/0001628280-25-021749.md) | [14.4 d](/filings/0001628280-25-037688.md) | [24.4 d](/filings/0001628280-25-047712.md) | [16.9 d](/filings/0001628280-26-012199.md) | [6.2](/filings/0001628280-26-031027.md) | [7.2 d](/filings/0001628280-26-052652.md) | [31.9 d](/filings/0001628280-25-047712.md) | [7.4 d](/filings/0001628280-26-012199.md) | [(2.9)](/filings/0001628280-26-031027.md) | [24.3 d](/filings/0001628280-26-052652.md) |
| Capital expenditure | $m | [5.9 d](/filings/0001628280-24-044893.md) | [6.7 d](/filings/0001628280-26-012199.md) | [6.4](/filings/0001628280-25-021749.md) | [9.6 d](/filings/0001628280-25-037688.md) | [8.3 d](/filings/0001628280-25-047712.md) | [7.8 d](/filings/0001628280-26-012199.md) | [6.1](/filings/0001628280-26-031027.md) | [5.6 d](/filings/0001628280-26-052652.md) | [3.6 d](/filings/0001628280-25-047712.md) | [4.4 d](/filings/0001628280-26-012199.md) | [7.0](/filings/0001628280-26-031027.md) | [6.2 d](/filings/0001628280-26-052652.md) |
| Dividends paid | $m | [4.9 d](/filings/0001628280-24-044893.md) | [20.9 d](/filings/0001628280-26-012199.md) | [4.8](/filings/0001628280-25-021749.md) | [5.2 d](/filings/0001628280-25-037688.md) | [5.2 d](/filings/0001628280-25-047712.md) | [5.2 d](/filings/0001628280-26-012199.md) | [5.2](/filings/0001628280-26-031027.md) | [5.2 d](/filings/0001628280-26-052652.md) | [5.2 d](/filings/0001628280-25-047712.md) | [5.3 d](/filings/0001628280-26-012199.md) | [5.3](/filings/0001628280-26-031027.md) | [5.3 d](/filings/0001628280-26-052652.md) |
| Share repurchases | $m | [3.2 d](/filings/0001628280-24-044893.md) | [3.7 d](/filings/0001628280-26-012199.md) | [0.0](/filings/0001628280-25-021749.md) | [0.0 d](/filings/0001628280-25-037688.md) | [0.0 d](/filings/0001628280-25-047712.md) | [5.0 d](/filings/0001628280-26-012199.md) | [2.0](/filings/0001628280-26-031027.md) | [0.0 d](/filings/0001628280-26-052652.md) | [0.0 d](/filings/0001628280-25-047712.md) | [2.8 d](/filings/0001628280-26-012199.md) | [2.0](/filings/0001628280-26-031027.md) | [14.6 d](/filings/0001628280-26-052652.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2010-06-30) | period not labelled (2010-09-30) | period not labelled (2011-03-31) | Q2 FY2011 (2011-06-30) | Q3 FY2011 (2011-09-30) | Q1 FY2012 (2012-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [18.1](/filings/0000216085-11-000032.md) | [22.0](/filings/0000216085-11-000044.md) | [18.5](/filings/0000216085-12-000014.md) | [18.6](/filings/0000216085-11-000032.md) | [22.2](/filings/0000216085-11-000044.md) | [22.3](/filings/0000216085-12-000014.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 0 at 2012-03-31, from the cover of the [10-Q filed 2012-05-07](/filings/0000216085-12-000014.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.